Our clients often refer to MJL as their best kept secret. We have been co-creating fantastic specialist healthcare brands for EMEA and the UK for over 30 years and are cited as one of the UK's fastest growing healthcare agencies. Get in touch to find out why
- Agency description
Successful healthcare brands thrive in a multi-channel, fast changing, ultra-competitive world. They respond appropriately to customer insight, innovate across media, and weave together unified content to create a consistent, behaviour-changing narrative.
They stay ahead by being unafraid to go into new and exciting places and they rely on experience, highly-skilled and dedicated teams to get them there.
We know this, because we are proven at delivering it.
We have 30 years’ experience under our belt, and were recently one of the fastest growing independent healthcare agencies in the UK1.
We have become seasoned communication specialists in secondary care medicine, launching brands at EMEA level before translating to local UK needs. Our brands thrive year on year due to our continued curiosity and determination to fully and continually understand the disease areas we work in, appreciate the role pharma companies and brands can play and drive a strong value offering through well thought through messaging and communication planning.
Fiercely independent, MJL is an energetic, curious and hard-working Agency. Every one of us individually recruited to add value. We have a Director as standard on every account to ensure all our clients, no matter how small, get our very best thinking.
Ref 1: Plimsoll Analysis
- Key contact
- Nina Buckley
- Managing Director
- 2021 Agency Data
- This information was supplied or confirmed by MJL. Bar charts are indicative only, with 100% being the maximum score allocated across all agencies. Billings from UK creative healthcare work are not a subset of total annual billings, and so may show a higher rating.
- Ranking factors contributing to agency score
- This chart shows the relative factors that contributed to the agency's overall ranking.
- PM Digitals GOLD 2021
PM Digitals Short Listed 2021
- This may contain additional awards supplied by MJL that were not included when generating this year’s T40 - please see methodology to find out which awards schemes were included.
COVID-19 Updates and Daily News
- Here are five of Art's top five pharma and healthcare picks from Cannes Lions 2022....
- The COVID-19 pandemic sparked an evolution in physician engagement. Jill Padgett, EdD, Head of Training, explores what this means for the sales force and shares her advice for succeeding in...
- Try our Omnichannel Maturity Tool to gain tangible advice and an instant analysis of your omnichannel readiness....
- Bristol Myers Squibb announces positive trial results for treatment of MS
- Dermavant publishes positive phase 3 data for treatment of plaque psoriasis
- Enanta takes legal action against Pfizer over Paxlovid patent infringement
- Moderna to launch Innovation and Technology Center in the UK
- Biogen and Happify Health team up to create digital platform for MS patients
- Novartis and Precision BioSciences announce in vivo gene editing collaboration
- NICE issues final draft recommending Novartis’ Scemblix to treat chronic myeloid leukaemia
- Alzheimer's Research UK supports government plans for clinical research
- GSK announces The HealthTree Foundation’s multiple myeloma programme as first ‘Think Tank’ challenge winner
- NRG Therapeutics partners with Domainex to develop neurodegenerative disease treatment
- Innovative Trials opens first US office
- Scanning for Health Indicators and Risks Through Your Smartphone
- Research from Imperial College London shows single brain scan could diagnose Alzheimer’s disease
- VMLY&R wins two Grand Prix awards at Cannes Lions International Festival of Creativity 2022
- How digital health is changing the relationship between patients and health providers | OPEN Health
- Novartis endorses Kigali Declaration by investing $250m for tropical diseases
- Roche shares new positive Ocrevus data for MS patients
- Six UK universities receive grant for research into motor neurone disease